Australia markets open in 5 hours 40 minutes

Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.97-0.07 (-0.87%)
As of 02:19PM EDT. Market open.
Full screen
Loading interactive chart…
  • GlobeNewswire

    Treace to Report Second Quarter 2024 Financial Results on August 6, 2024

    PONTE VEDRA, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that it will release financial results for the second quarter of 2024 after the close of trading on Tuesday, August 6, 2024. Company management will host a conferenc

  • GlobeNewswire

    Treace to Present at Truist Securities MedTech Conference

    Tuesday, June 18, 2024 at 8:00 am Eastern TimePONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside

  • GuruFocus.com

    Director Jane Kiernan Acquires 19,356 Shares of Treace Medical Concepts Inc (TMCI)

    On May 14, 2024, Director Jane Kiernan purchased 19,356 shares of Treace Medical Concepts Inc (NASDAQ:TMCI), as reported in the SEC Filing.